{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:08:42Z","timestamp":1788876522942,"version":"build-2803163510"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jneuroim.2026.579039","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T23:53:44Z","timestamp":1784678024000},"page":"579039","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Presenting and residual movement disorders in all-cause autoimmune encephalitis"],"prefix":"10.1016","volume":"420","author":[{"given":"Samhitha M.","family":"Rai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia F.","family":"Damman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijoya","family":"Basu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Elkasaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aasef G.","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5346-8254","authenticated-orcid":false,"given":"Hesham","family":"Abboud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jneuroim.2026.579039_bb0005","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1007\/s00415-017-8627-4","article-title":"Neuronal autoantibodies: differentiating clinically relevant and clinically irrelevant results","volume":"264","author":"Abboud","year":"2017","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579039_bb0010","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1212\/CPJ.0000000000000560","article-title":"Movement disorders in early MS and related diseases: a prospective observational study","volume":"9","author":"Abboud","year":"2019","journal-title":"Neurol Clin Pract"},{"key":"10.1016\/j.jneuroim.2026.579039_bb0015","article-title":"Residual symptoms and long-term outcomes after all-cause autoimmune encephalitis in adults","volume":"434","author":"Abboud","year":"2021","journal-title":"J Neurol Sci"},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579039_bb0020","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s12028-019-00875-5","article-title":"Treatment of movement disorder emergencies in autoimmune encephalitis in the neurosciences ICU","volume":"32","author":"Ali","year":"2020","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.jneuroim.2026.579039_bb0025","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jns.2017.12.035","article-title":"Autoimmune and paraneoplastic movement disorders: an update","volume":"385","author":"Baizabal-Carvallo","year":"2018","journal-title":"J Neurol Sci"},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579039_bb0030","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/brain\/awx189","article-title":"Movement disorders with neuronal antibodies: syndromic approach, genetic parallels and pathophysiology","volume":"141","author":"Balint","year":"2018","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.jneuroim.2026.579039_bb0035","doi-asserted-by":"crossref","first-page":"E244","DOI":"10.1212\/WNL.0000000000006783","article-title":"A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis","volume":"92","author":"Balu","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2026.579039_bb0040","article-title":"Movement disorders after stroke in adults: a review","volume":"2","author":"Bansil","year":"2012","journal-title":"Tremor Other Hyperkinet Mov"},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579039_bb0045","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/cap.2014.0084","article-title":"Clinical evaluation of youth with pediatric acute-onset neuropsychiatric syndrome (PANS): recommendations from the 2013 PANS consensus conference","volume":"25","author":"Chang","year":"2015","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jneuroim.2026.579039_bb0050","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jocn.2018.10.076","article-title":"Proportion and spectrum of movement disorders in adolescent and adult patients of autoimmune encephalitis of non-neoplastic aetiology","volume":"59","author":"Dash","year":"2019","journal-title":"J Clin Neurosci"},{"issue":"19","key":"10.1016\/j.jneuroim.2026.579039_bb0055","doi-asserted-by":"crossref","first-page":"E2185","DOI":"10.1212\/WNL.0000000000007475","article-title":"Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABABR encephalitis","volume":"92","author":"De Bruijn","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2026.579039_bb0060","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jneuroim.2018.07.009","article-title":"Predictors of neural-specific autoantibodies and immunotherapy response in patients with cognitive dysfunction","volume":"323","author":"Dubey","year":"2018","journal-title":"J Neuroimmunol"},{"issue":"2","key":"10.1016\/j.jneuroim.2026.579039_bb0065","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/brain\/awac276","article-title":"Distinct movement disorders in contactin-associated-protein-like-2 antibody-associated autoimmune encephalitis","volume":"146","author":"G\u00f6vert","year":"2023","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.jneuroim.2026.579039_bb0070","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.jneuroim.2026.579039_bb0075","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ana.24200","article-title":"Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms","volume":"76","author":"Irani","year":"2014","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579039_bb0080","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s00415-023-12003-7","article-title":"Pathological findings in autoimmune encephalitis autopsy specimens from cases of suspected prion disease","volume":"271","author":"Kerner","year":"2024","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.jneuroim.2026.579039_bb0085","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200516","article-title":"Movement disorders in antibody-associated neurologic diseases: a Nationwide study","volume":"13","author":"Kerstens","year":"2026","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"10","key":"10.1016\/j.jneuroim.2026.579039_bb0090","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1093\/brain\/awac166","article-title":"Seronegative autoimmune encephalitis: clinical characteristics and factors associated with outcomes","volume":"145","author":"Lee","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2026.579039_bb0095","article-title":"Analysis of characteristics of movement disorders in patients with anti-N-methyl-D-aspartate receptor encephalitis","volume":"15","author":"Li","year":"2024","journal-title":"Front Neurol"},{"key":"10.1016\/j.jneuroim.2026.579039_bb0100","doi-asserted-by":"crossref","unstructured":"Lim JA, Lee ST, Moon J, Jun JS, Kim TJ, Shin YW, Abdullah S, Byun JI, Sunwoo JS, Kim KT, Yang TW, Lee WJ, Moon HJ, Kim DW, Lim BC, Cho YW, Yang TH, Kim HJ, Kim YS, Koo YS, Park B, Jung KH, Kim M, Park KI, Jung KY, Chu K, Lee SK. Development of the clinical assessment scale in autoimmune encephalitis. Ann Neurol 2019 Mar;85(3):352\u2013358. doi:https:\/\/doi.org\/10.1002\/ana.25421. Epub 2019 Feb 10. PMID: 30675918.","DOI":"10.1002\/ana.25421"},{"issue":"6","key":"10.1016\/j.jneuroim.2026.579039_bb0105","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000178","article-title":"Pathologically confirmed autoimmune encephalitis in suspected Creutzfeldt-Jakob disease","volume":"2","author":"Maat","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"JUN","key":"10.1016\/j.jneuroim.2026.579039_bb0110","article-title":"Analysis of clinical characteristics and poor prognostic predictors in patients with an initial diagnosis of autoimmune encephalitis","volume":"10","author":"Qiu","year":"2019","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.jneuroim.2026.579039_bb0115","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/mus.23234","article-title":"Autoimmune stiff person syndrome and related myelopathies: understanding of electrophysiological and immunological processes","volume":"45","author":"Rakocevic","year":"2012","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2026.579039_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1225523","article-title":"Movement disorders in cell surface antibody mediated autoimmune encephalitis: a meta-analysis","volume":"14","author":"Siriratnam","year":"2023","journal-title":"Front Neurol"},{"issue":"8","key":"10.1016\/j.jneuroim.2026.579039_bb0125","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2024-334957","article-title":"Autoimmune encephalitis: recovery, residual symptoms and predictors of long-term sequelae","volume":"96","author":"Thakolwiboon","year":"2025","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1016\/j.jneuroim.2026.579039_bb0130","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1136\/jnnp-2018-318584","article-title":"The movement disorder associated with NMDAR antibody-encephalitis is complex and characteristic: an expert video-rating study","volume":"90","author":"Varley","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jneuroim.2026.579039_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00991","article-title":"Immunological bases of paraneoplastic cerebellar degeneration and therapeutic implications","volume":"11","author":"Yshii","year":"2020","journal-title":"Front Immunol"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572826001888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572826001888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:24:53Z","timestamp":1788873893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572826001888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":27,"alternative-id":["S0165572826001888"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2026.579039","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Presenting and residual movement disorders in all-cause autoimmune encephalitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2026.579039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"579039"}}